The present invention disclosed herein is a low dose pharmaceutical composition comprising deferasirox along with one or more pharmaceutically acceptable excipients. The present invention also disclosed a process for preparation of such low dose pharmaceutical composition and its use in the treatment of chronic iron overload and lead toxicity.